FDA Approve Claim That High-Amylose Maize Resistant Starch Reduces Type 2 Diabetes Risk


19 Dec 2016 --- Ingredion Incorporated has announced that the U.S. Food and Drug Administration (FDA) has approved its a petition to communicate the relationship between high-amylose maize resistant starch and a reduced risk of Type 2 diabetes on the packages of conventional foods.

In reviewing Ingredion’s petition, the FDA concluded that there was scientific evidence for a qualified health claim for high-amylose maize resistant starch and reduced risk of Type 2 diabetes, while ensuring the claim was appropriately worded so as not to be misleading.

“High-amylose maize resistant starch may reduce the risk of Type 2 diabetes. FDA has concluded that there is limited scientific evidence for this claim,” says Anthony DeLio, chief innovation officer for Ingredion Incorporated.

These claims can be used on the packaging of conventional foods, as defined by 21 CFR 101.14. Such products include bakery items, nutrition bars, cereals and pastas among others.

Discussing the future of the ingredient, Lorraine Niba, PhD, MBA, Global Director, Nutrition Innovation, Ingredion Incorporated tells FoodIngredientsFirst, “Application areas such as pastas, breads and nutritional snacks where consumers have concerns about highly digestible carbohydrates can be boosted by the ability to use a complex carbohydrate like HI-MAIZE resistant starch.”

“Not only is it an option when formulating for healthier pastas or breads, HI-MAIZE resistant starch is easy to use, blends very easily into flours, and does not impact color or flavour,” she explains.

“As a non-GMO and clean label resistant starch, it is also very label friendly as an ingredient. We believe the new qualified health claim is a positive development for consumers as it provides another pragmatic approach to potential diabetes risk reduction through everyday foods.”

Niba adds, “We believe the new qualified health claim is a positive development for consumers as it provides another pragmatic approach to potential diabetes risk reduction through everyday foods.”

The company say that investing in the research to obtain a qualified health claim is a strong indication of its long-term commitment to advancing its Nutrition Innovation programs to deliver “ground breaking, relevant and clinically substantiated ingredients.”

The company has also secured qualified health claims in other regions.

“HI-MAIZE resistant starch has a Glycemic Reduction EFSA claim in Europe, as well as a General Level Digestive Health Claim in Australia,” says Niba.

“Ingredion has built a body of science on HI-MAIZE resistant starch over several years of clinical research. Our Nutrition Innovation programs are committed to science-based nutritional ingredient solutions that address key consumer needs such as diabetes risk reduction.”

The qualified health claim petition was based on eight clinical trials conducted at academic institutions and research organizations, which assessed the impact of HI-MAIZE high-amylose maize resistant starch on insulin sensitivity and other biomarkers.

by Hannah Gardiner

To contact our editorial team please email us at editorial@cnsmedia.com

Ingredion Incorporated


We are a global ingredient solutions company built on a rich legacy of exceptional performance and market-leading innovation. Our geographic footprint and diverse organisation give us the capability to deliver solutions on a global scale and the agility to meet the needs of local markets.

We make it our business to understand industry trends and our customers’ challenges. They trust us to anticipate and deliver the consistently high-quality products and innovative solutions they need.

Each day, we live our Company Values—Safety, Quality, Integrity, Respect, Excellence and Innovation—so that we may create enduring, mutual value for our customers, business associates, communities, colleagues and shareholders.

Related Articles

Food Ingredients News

Ingredion CEO on M&A: “I want us to be bolder and bigger in our thinking”

27 Jul 2018 --- New Ingredion CEO, Jim Zallie is targeting strong growth for his company in specialty ingredients, which will be partly achieved through further acquisitions. M&A activity will almost certainly follow in the form of bolt-ons, but even something more transformational such as a major merger would be considered. “The exciting part about our company is that we have a strong balance sheet,” he says in a detailed exclusive interview with FoodIngredientsFirst. “The opportunity for bolt-on acquisitions would be a sweet spot for us, but equally, if an opportunity to be transformational that was more sizeable opened up, we are willing and interested in doing that as well. We are not narrowly focused, nor afraid of a tremendous opportunity to grow and build our portfolio.”

Food Ingredients News

Stevia science report assesses development behind the natural sweetener

25 Jul 2018 --- An in-depth review of the latest stevia science has been published in the Journal of Nutrition exploring its benefits and future potential as stevia adoption in global food and beverage products increases. Nutritionist scientists, healthcare practitioners and consumers have shown a growing interest in stevia science and safety as its popularity continues to grow.

Food Ingredients News

Start-up success: Boxed water company secures US$6.7m investment led By AccelFoods

24 Jul 2018 --- Rethink Brands, the boxed water company disrupting the children's beverage sector with the creation of Rethink Kids Water, has received a US$6.7 million investment for growth and expansion. The latest round of funding is led by AccelFoods, investors in high-growth, natural food and beverage companies.

Business News

The consolidating ingredients sector: Ingredion convergence epitomizes a tightening sector

23 Jul 2018 --- The integration of several portfolios into a single larger ingredient entity was a key theme at the IFT 2018 Food Expo in Chicago last week. The relatively small trade show floor was a reminder of how many previous exhibiting companies have been swallowed up over recent years, in order to be integrated into the likes of DSM (e.g. Martek, Ocean Nutrition Canada and Fortitech), Kerry (e.g. Ganeden, Red Arrow and Biothera), ADM (Wild Flavors) and IFF (Ottens Flavors and David Michael). Naturex (currently being acquired by Givaudan) could be the next to disappear from a show floor, amid a consolidating ingredients world, where questions must soon be raised about a growing lack of competition and diversity in ultimate holding companies.

Food Ingredients News

Cambridge Commodities acquires ingredient business of US wholesaler Earth Circle Organics

19 Jul 2018 --- UK-based ingredient supplier Cambridge Commodities has acquired the ingredient business of US wholesaler Earth Circle Organics LLC, for an undisclosed sum. Following the acquisition, Earth Circle Organics’ raw and organic superfood ingredient business will merge with the US arm of Cambridge Commodities to create a new division, operating as Earth Circle Ingredients.

More Articles